Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,411 GBX | -0.14% | +0.10% | +16.87% |
01:20pm | ASTRAZENECA : Goldman Sachs maintains a Buy rating | ZD |
10:34am | AstraZeneca disappointed by breast cancer drug trial results | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.87% | 244B | |
+51.86% | 797B | |
+40.51% | 628B | |
-6.68% | 351B | |
+17.08% | 323B | |
+10.46% | 300B | |
+1.02% | 223B | |
+5.68% | 163B | |
-5.49% | 153B | |
-1.53% | 118B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca's Tagrisso Secures Priority Review in the US